上一节我们讲述了大血管病变的传统危险因素与胰岛素抵抗之间的关系和罗格列酮对传统危险因素的作用。本节我们将继续阐述大血管病变的非传统危险因素与胰岛素抵抗之间的关系,并进一步阐述罗格列酮针对非传统危险因素的治疗。1 大血管病变的非传统危险因素 现已证实,单独的大血管病变的传统危险因素,如血脂异常和血压升 In the previous section, we described the relationship between traditional and macrovascular risk factors and insulin resistance and the effects of rosiglitazone on traditional risk factors. In this section we will continue to describe the relationship between non-traditional risk factors for macrovascular disease and insulin resistance and to further describe the treatment of non-traditional risk factors by rosiglitazone. A large non-traditional risk factors for macrovascular disease has confirmed that the traditional risk factors for macrovascular disease alone, such as dyslipidemia and blood pressure rise